NDLR 2010
New Directions in Leukaemia Research
Novotel Twin Waters, Sunshine Coast, QLD, Australia
28 - 31 March 2010
NDLR 2010
  • Home
  • REGISTRATION NOW OPEN
  • Program
  • International Speakers
    • National Speakers
  • Sponsorship Opportunities
  • Venue and Destination
  • Student and Postdoctoral Prize
  • Committee
  • Accommodation
  • Contact Details
  • LFA Young Researcher's Forum
  • NDLR Conference 2008
LF logo

The Leukaemia Foundation is proud to host the New Directions in Leukaemia Research Conference

Principal Sponsor

Novartis Principal Sponsor
Register-Now-Button

Invitation

The Scientific and Organising Committees would like to invite you to be a part of the The 3rd New Directions in Leukaemia Research (NDLR) meeting that will be held on the Sunshine Coast, Queensland, Australia from Sunday March 28th to Wednesday March 31st 2010. 

Click here to download the 1st Announcement Flyer.

The over-arching goals of the NDLR series of meetings are to bring together scientists and clinicians to discuss and debate current concepts in our understanding of the molecular basis of leukaemia, emerging paradigms, breakthroughs at the forefronts of leukaemia research and new therapies emerging in the clinic.

The NDLR series of meetings has established an international reputation for bringing together leaders in both basic and clinical leukaemia research covering the full spectrum of "bench to clinic" translational research (2008 Speakers).

Leukaemia research is a rapidly evolving field and in recent times has undergone an unprecedented revolution promising a real and significant impact in the clinic. The New Directions in Leukaemia Research Conference is the only biennial series of international meetings focused on leukaemia and therefore offers a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field.

We look forward to seeing you at NDLR2010.

Confirmed Speakers

To date the following speakers have confirmed their attendance at NDLR 2010

CONFIRMED INTERNATIONAL SPEAKERS
Michael Deininger - Oregon Health and Science University Cancer
Institute, Portland USA
Gary Gilliland - Merck and Co., Inc., Philadelphia USA
Tony Green - Cambridge Institute for Medical Research, Cambridge UK
Charles Mullighan - St. Jude Children's Research Hospital, Memphis USA
Paolo Pandolfi - Beth Israel Deaconess Medical Center, Boston USA
Nikolaus Rajewsky - Max Delbruck Center for Molecular Medicine, Berlin Germany
Daniel Tenen - Harvard Medical School, Boston USA and University of Singapore,

CONFIRMED NATIONAL SPEAKERS
Warren Alexander - Walter and Eliza Hall Institute of Medical Research, Melbourne
Andrew Boyd - Queensland Institute of Medical Research, Brisbane
Suzanne Cory - Walter and Eliza Hall Institute of Medical Research, Melbourne
David Curtis - Bone Marrow Research Laboratories, Melbourne
Timothy Hughes - Centre for Cancer Biology, SA Pathology, Adelaide
Richard Lock - Children's Cancer Institute Australia, Sydney
Grant McArthur - Peter MacCallum Cancer Centre, Melbourne
Murray Norris - Children's Cancer Institute Australia, Sydney
Andrew Roberts - Walter and Eliza Hall Institute of Medical, Research, Melbourne
Clare Scott - Walter and Eliza Hall Institute of Medical, Research, Melbourne
Carl Walkley - St Vincent's Institute, Melbourne


 

Conference Sponsors

Gold Sponsor

BMS Oncology300 for web

Silver Sponsor

CSL

Internet Cafe Sponsor

celgene logo 3

Welcome Reception Sponsor

Chemgenex for website

Poster Session Sponsor

Roche Logo

Young Investigator Travel Bursary Sponsor

HospiraHaematology

Note Pad and Pens Sponsor

Philiips Ormonde Fitzpatrick Logo for website